Although an unspecific Mac-1 blockade might, therefore, in theory, also predispose towards infection, we argue that the risk can be significantly reduced by specifically targeting only the activated receptor conformation (as with F7) leaving the functions of the non-activated Mac-1 receptor intact. This evidence concerns the gene ITGB2 and infection.